Polymerase Chain Reaction (PCR) Consumables Market Trends

The increasing prevalence of infectious diseases is a significant driver for polymerase chain reaction (PCR) consumables industry. PCR-based assays are highly sensitive, specific, and versatile, making them invaluable tools for the detection and characterization of infectious agents such as viruses, bacteria, fungi, and parasites.

• According to the World Health Organization (WHO), in 2023, there are more than 39 million people suffering from HIV. As per the same report, HIV prevalence is the largest among adult males and is surging at a rapid pace.
  
• Similarly, according to the National Institutes of Health, in 2022, number of new tuberculosis cases rose to 8,916 in the U.S. Further, number of new salmonella cases jumped to 58,371 in the country. Thus, leading to increase in respiratory disease testing, ultimately utilizing the PCR consumables.
  
• Infectious disease outbreaks, epidemics, and pandemics pose significant public health challenges and require rapid response measures to contain transmission and mitigate impact. PCR technology enables rapid and reliable detection of infectious agents in clinical samples, environmental samples, and surveillance systems.
  
• The emergence and re-emergence of infectious pathogens, including novel viruses, antibiotic-resistant bacteria, and zoonotic infections, drive the need for advanced diagnostic tools capable of detecting and characterizing these pathogens. Consequently, there is a growing demand for PCR consumables to support research, surveillance, and diagnostic activities related to emerging infectious diseases.